Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Total Current Liabilities (2020 - 2025)

SOPHiA GENETICS's Total Current Liabilities history spans 6 years, with the latest figure at $50.5 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 88.52% to $50.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.5 million, a 88.52% increase, with the full-year FY2025 number at $50.5 million, up 88.52% from a year prior.
  • Total Current Liabilities hit $50.5 million in Q4 2025 for SOPHiA GENETICS, up from $36.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SOPH hit a ceiling of $50.5 million in Q4 2025 and a floor of $24.9 million in Q2 2021.
  • Historically, Total Current Liabilities has averaged $31.0 million across 5 years, with a median of $29.3 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: dropped 24.76% in 2024 and later soared 88.52% in 2025.
  • Tracing SOPH's Total Current Liabilities over 5 years: stood at $28.6 million in 2021, then dropped by 6.27% to $26.8 million in 2022, then soared by 32.86% to $35.6 million in 2023, then dropped by 24.76% to $26.8 million in 2024, then soared by 88.52% to $50.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for SOPH at $50.5 million in Q4 2025, $36.9 million in Q3 2025, and $34.5 million in Q2 2025.